ARCHIVES

CTI Files Appeal Over FDA’s Decision on Pixantrone

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

In Setback For Generics, Court Overturns FDA.

November 9, 2001

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Obituary: Ellen Tobin, Consultant, Championed Patients’ Needs;

January 10, 2003

Preventive Services Task Force Urges Colorectal Cancer Screening for 50 and Up; Advises Against Tamoxifen for Women at Low to Average Breast Cancer Risk

July 19, 2002

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

In Brief: FDA Commissioner Kessler Named Dean, Yale Medical School, Effective July 1

February 21, 1997